ITONF: Pre-immunotherapy Nursing Education Programme

QUESTIONS TO BE COMPLETED BEFORE UNDERTAKING THE EDUCATION PROGRAMME

Thank you for registering for the International Thoracic Oncology Nursing Forum Immunotherapy Nursing Education Programme, which is designed to provide you with critical insights into the current management of advanced/metastatic non-small cell lung cancer (NSCLC).

We would be grateful if you could complete this short questionnaire to help gauge your current knowledge on the topics covered in this programme. You will be invited to complete a similar questionnaire once you have completed the programme to help with evaluation.

This questionnaire should take no more than 2–3 minutes of your time.

Question Title

* 1. Please indicate on a scale of 1 to 4 your response to the following statements.
I am confident that I can describe:

  4  Strongly Agree 3 Agree 2 Disagree 1 Strongly Disagree
The histological and molecular subtypes of lung cancer
The treatment and care of the lung cancer patient with advanced/ metatistic NSCLC with no actionable mutations (Stage IIIB-IV)
The treatment and care of the lung cancer patient with PD-L1 high NSCLC (Stage IIIB-IV)
The treatment and care of the lung cancer patient with EGFRm NSCLC (Stage IIIB-IV)
The treatment and care of the lung cancer patient with ALK+ NSCLC (Stage IIIB-IV)
Care Strategies for patients living with lung cancer

T